Bültmann & Gerriets
Advances in Breast Cancer Management, 2nd edition
von William J. Gradishar, William C. Wood
Verlag: Springer New York
Reihe: Cancer Treatment and Research Nr. 103
E-Book / PDF
Kopierschutz: PDF mit Wasserzeichen

Hinweis: Nach dem Checkout (Kasse) wird direkt ein Link zum Download bereitgestellt. Der Link kann dann auf PC, Smartphone oder E-Book-Reader ausgeführt werden.
E-Books können per PayPal bezahlt werden. Wenn Sie E-Books per Rechnung bezahlen möchten, kontaktieren Sie uns bitte.

ISBN: 978-1-4757-3147-7
Auflage: 2000
Erschienen am 09.03.2013
Sprache: Englisch
Umfang: 211 Seiten

Preis: 85,59 €

85,59 €
merken
Inhaltsverzeichnis
Klappentext

1. Managing Menopausal Problems.- 2. Sentinel Lymphadenectomy in Node Negative Breast Cancer.- 3. Postmastectomy Radiotherapy.- 4. The Molecular and Cellular Biology of HER2/neu Gene Amplification/ Overexpression and the Clinical Development of Herceptin (Trastuzumab Therapy for Breast Cancer.- 5. High-Dose Chemotherapy for Breast Cancer.- 6. High Dose Therapy with Stem Cell Support for Breast Cancer: The Jury Is Still Out.- 7. Preoperative Chemotherapy for Operable Breast Cancer.- 8. Overview of Randomized Trials of Systemic Adjuvant Therapy.- 9. Chemoprevention of Breast Cancer.



The optimal management of breast cancer patients relies on the expertise of a team of medical specialists including radiologists, surgeons, radiation therapists and medical oncologists. Much of the progress in breast cancer management made over the last several years reflects the translation of observations made in the laboratory to the clinic. Critically evaluating the impact of new treatment approaches relies on a commitment to well-designed clinical trials. In this volume, Advances in Breast Cancer Management, a renowned group of breast cancer experts have been asked to provide their perspective on management issues that directly effect patients on a day-to-day basis. Dr. Melody Cobleigh discusses the consequences of estrogen deprivation and the ways of ameliorating secondary symptoms and the potential long-term morbidity. Drs. Haigh and Guiliano review the sentinel lymph node biopsy technique including results from their extensive experience. Dr. Abram Recht places into perspective the potential benefit of post-mastectomy radiotherapy and reviews recent trials that address this issue. Dr. Dennis Slamon takes from us from the laboratory to the clinic in explaining the development of Herceptin as a paradigm for therapy targeted to specific molecular characteristics of breast cancer tumor cells. Drs. Nieto, Shpall, Crump and Pritchard offer different perspectives on the future of high-dose chemotherapy with stem cell transplantation as a treatment for breast cancer patients. Drs.


weitere Titel der Reihe